MedPath

UNIVERSITY OF MIAMI

UNIVERSITY OF MIAMI logo
🇺🇸United States
Ownership
Private
Established
1925-01-01
Employees
10K
Market Cap
-
Website
https://continue.miami.edu/packagedetail.aspx

Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study

Not Applicable
Not yet recruiting
Conditions
Cancer
First Posted Date
2025-05-01
Last Posted Date
2025-05-01
Lead Sponsor
University of Miami
Target Recruit Count
25
Registration Number
NCT06952790
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Neural and Psychiatric Consequences of Cannabis Use in Adolescents

Not Applicable
Recruiting
Conditions
Cannabis Use
Depression
First Posted Date
2025-04-23
Last Posted Date
2025-04-23
Lead Sponsor
University of Miami
Target Recruit Count
280
Registration Number
NCT06941298
Locations
🇺🇸

University of Miami Clinical Research Building, Miami, Florida, United States

🇺🇸

Nathan Kline Institute, Orangeburg, New York, United States

Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety

Not Applicable
Completed
Conditions
COVID-19
First Posted Date
2025-04-22
Last Posted Date
2025-04-30
Lead Sponsor
University of Miami
Target Recruit Count
112
Registration Number
NCT06938230
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Adjuvant Quisinostat in High-Risk Uveal Melanoma

Phase 2
Recruiting
Conditions
Uveal Melanoma
Interventions
First Posted Date
2025-04-17
Last Posted Date
2025-05-14
Lead Sponsor
University of Miami
Target Recruit Count
63
Registration Number
NCT06932757
Locations
🇺🇸

University of Miami, Miami, Florida, United States

The Test-to-PrEP Study

Not Applicable
Recruiting
Conditions
HIV Infections
First Posted Date
2025-04-15
Last Posted Date
2025-04-18
Lead Sponsor
University of Miami
Target Recruit Count
320
Registration Number
NCT06927856
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

Phase 2
Not yet recruiting
Conditions
Large B-cell Lymphoma
Relapse
Interventions
First Posted Date
2025-04-09
Last Posted Date
2025-04-09
Lead Sponsor
University of Miami
Target Recruit Count
26
Registration Number
NCT06919939
Locations
🇺🇸

University of Miami, Miami, Florida, United States

CtDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

Phase 2
Not yet recruiting
Conditions
Non Small Cell Lung Cancer
Interventions
Diagnostic Test: Circulating Tumor Deoxyribonucleic acid (ctDNA) Assay
First Posted Date
2025-03-30
Last Posted Date
2025-03-30
Lead Sponsor
University of Miami
Target Recruit Count
30
Registration Number
NCT06902272
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Phase 2
Not yet recruiting
Conditions
Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Interventions
Radiation: TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization
First Posted Date
2025-03-30
Last Posted Date
2025-03-30
Lead Sponsor
University of Miami
Target Recruit Count
28
Registration Number
NCT06902246
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Phase 4
Recruiting
Conditions
Sleep
Knee Osteoarthritis
Interventions
Drug: Magnesium Threonate
Other: Control
First Posted Date
2025-03-30
Last Posted Date
2025-04-24
Lead Sponsor
University of Miami
Target Recruit Count
64
Registration Number
NCT06902285
Locations
🇺🇸

University of Miami Hospital, Miami, Florida, United States

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

Not Applicable
Not yet recruiting
Conditions
Pancreatic Cancer
First Posted Date
2025-03-25
Last Posted Date
2025-03-25
Lead Sponsor
University of Miami
Target Recruit Count
60
Registration Number
NCT06893276
Locations
🇺🇸

University of Miami, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath